December 2025
1. SONG TX, Sun YD, Zhang B, Xuan Y, et al
   Multivariate and survival analysis of prognosis and surgical benefits in infective endocarditis.
   Scand Cardiovasc J. 2025;59:2429994.
   

   >> Share

   
   
2. HOYDAHL MP, Kjonas D, Rosner A, Trones Antonsen B, et al
   Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation.
   Scand Cardiovasc J. 2025;59:2481175.
   

   >> Share

   
   
3. HEROU E, Mortsell E, Grubb A, Nozohoor S, et al
   Shrunken pore syndrome in heart transplantation: a pore ready to close?
   Scand Cardiovasc J. 2025;59:2481173.
   

   >> Share

   
   
4. GRANATH C, Dismorr M, Bjorck HM, Carlestal E, et al
   Aortic valve phenotype and distal aortic outcome after ascending aortic surgery.
   Scand Cardiovasc J. 2025;59:2513874.
   

   >> Share

   
   
5. ALBAGE A, Granfeldt H, Vanky F
   Minimally invasive mitral valve surgery in a non-high volume center.
   Scand Cardiovasc J. 2025;59:2514743.
   

   >> Share

   
   
6. STEEN S, Liao Q, Pascevivius A, Li M, et al
   Ex vivo resuscitation and evaluation of hearts after 22 minutes of normothermic cardiac arrest.
   Scand Cardiovasc J. 2025;59:2525098.
   

   >> Share

   
   June 2025
7. RIIHINIEMI M, Piuhola J, Niemela M, Biancari F, et al
   Percutaneous coronary intervention in nonagenarians.
   Scand Cardiovasc J. 2025 Jun 2:1-11. doi: 10.1080/14017431.2025.2514880.
   

   >> Share

   
   December 2024
8. VAN DER LINDEN J, Fux T, Kaakinen T, Rutanen J, et al
   In Nordic countries 30-day mortality rate is half that estimated with EuroSCORE II in high-risk adult patients given aprotinin and undergoing mainly complex cardiac procedures.
   Scand Cardiovasc J. 2024;58:2330347.
   

   >> Share

   
   
9. WICKBOM A, Fengsrud E, Alfredsson J, Engdahl J, et al
   Atrial fibrillation incidence after coronary artery bypass graft surgery and percutaneous coronary intervention: the prospective AFAF cohort study.
   Scand Cardiovasc J. 2024;58:2347297.
   

   >> Share

   
   
10. QIU J, Li L, Wang W, Li X, et al
    Jailed high-pressure balloon technique is superior to jailed wire technique in protecting side branch of coronary bifurcation lesions.
    Scand Cardiovasc J. 2024;58:2347295.
    

    >> Share

    
    
11. MULLER M, Hanssen TA, Johansen D, Jakobsen O, et al
    Validity of a smartwatch for detecting atrial fibrillation in patients after heart valve surgery: a prospective observational study.
    Scand Cardiovasc J. 2024;58:2353069.
    

    >> Share

    
    
12. LARSSON M, Nozohoor S, Ede J, Herou E, et al
    Biomarkers of inflammation and coagulation after minimally invasive mitral valve surgery: a prospective comparison to conventional surgery.
    Scand Cardiovasc J. 2024;58:2347293.
    

    >> Share

    
    
13. LIU Y, Li X, Liu Z, Lu C, et al
    A nomogram for prediction of early mortality in patients undergoing cardiac surgery for infective endocarditis: a retrospective single-center study.
    Scand Cardiovasc J. 2024;58:2373084.
    

    >> Share

    
    
14. ZHU T, Li D, Qiao J, Li Q, et al
    Accuracy of subtraction fractional flow reserve with computed tomography in identifying early revascularization in patients with coronary artery disease.
    Scand Cardiovasc J. 2024;58:2373082.
    

    >> Share

    
    
15. KAVLIE TL, Kildahl HA, Dalen H, Nordhaug DO, et al
    Five-year outcomes of mitral valve repair for leaflet prolapse at a medium-sized Norwegian university hospital.
    Scand Cardiovasc J. 2024;58:2379336.
    

    >> Share

    
    
16. WESTERDAHL E, Bergh C, Urell C
    Patient-reported physical activity, pain, and fear of movement after cardiac surgery: a descriptive cross-sectional study.
    Scand Cardiovasc J. 2024;58:2393311.
    

    >> Share

    
    
17. KLEMENTSSON V, Bhat M, Steding-Ehrenborg K, Hedstrom E, et al
    Non-invasive pressure-volume loops show high arterial elastance in children with repaired tetralogy of Fallot.
    Scand Cardiovasc J. 2024;58:2418085.
    

    >> Share

    
    June 2024
18. MOVAHED MR
    Common practice of underreporting and downplaying adverse events and exaggerating benefits in patients undergoing percutaneous coronary intervention of chronic total occlusions.
    Scand Cardiovasc J. 2024;58:2373070.
    

    >> Share

    
    
19. MANSIKKANIEMI L, Miyashita H, Sinisalo J, Stewart J, et al
    A reply to the letter to the editor "Common practice of underreporting and downplaying adverse events and exaggerating benefits in patients undergoing percutaneous coronary intervention of chronic total occlusions".
    Scand Cardiovasc J. 2024;58:2373102.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share